Case report: rhabdomyolysis induced by mibefradil in a patient treated with cyclosporine and simvastatin.
作者信息
Wombolt D G, Jackson A, Punn R, Smith S, McCune T R, Williams P B
机构信息
Nephrology Associates of Tidewater, Eastern Virginia Medical School, Norfolk, VA, USA.
出版信息
J Clin Pharmacol. 1999 Mar;39(3):310-2.
PMID:10073331
Abstract
摘要
相似文献
1
Case report: rhabdomyolysis induced by mibefradil in a patient treated with cyclosporine and simvastatin.
J Clin Pharmacol. 1999 Mar;39(3):310-2.
2
Rhabdomyolysis due to interaction of simvastatin with mibefradil.辛伐他汀与米贝拉地尔相互作用导致的横纹肌溶解症。
Lancet. 1998 Jun 27;351(9120):1929-30. doi: 10.1016/S0140-6736(05)78613-X.
3
[Induction of bradycardia by mibefradil in antihypertensive combination therapy].
Dtsch Med Wochenschr. 1998 Apr 24;123(17):547.
4
Mibefradil (posicor).
Compr Ther. 1997 Nov;23(11):761-3.
5
6
Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis.环孢素治疗葡萄膜炎后辛伐他汀诱发的横纹肌溶解症。
Ocul Immunol Inflamm. 2007 Jul-Aug;15(4):345-6. doi: 10.1080/09273940701375147.
7
Simvastatin-induced rhabdomyolysis in a CsA-treated renal transplant recipient.辛伐他汀诱导的横纹肌溶解症在一名接受环孢素A治疗的肾移植受者中发生。
Med Sci Monit. 2003 Sep;9(9):CS89-91.
8
Mibefradil withdrawn from the market.
Ann Pharmacother. 1998 Jul-Aug;32(7-8):841. doi: 10.1345/aph.17356.
9
Serious interaction between mibefradil and tacrolimus.
Transplantation. 1998 Oct 27;66(8):1113-5. doi: 10.1097/00007890-199810270-00026.
10
[Current therapy of coronary heart disease. Conservative measures].[冠心病的当前治疗方法。保守措施]
Internist (Berl). 1998 Sep;39(9):1001-2.
引用本文的文献
1
Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.他汀类药物的不良反应：文献综述及线粒体机制证据
Am J Cardiovasc Drugs. 2008;8(6):373-418. doi: 10.2165/0129784-200808060-00004.
Zotero 插件